Singulex Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Singulex Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011443
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and physicians in identifying the biomarkers of disease. Singulex’s SMC technology offer ultrasensitive lab testing services for facilitating proactive health management. The company also provides immunoassay kits and reagents and immunoassay systems. It offers services such as clinical lab testing, patient lab testing, wellness programs, clinical laboratory consulting and billing and client services. The company’s technology is used for medical practice or clinical diagnostics and scientific research applications. Singulex is headquartered in Alameda, California, the US.

Singulex Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Singulex Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Singulex Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Singulex Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Singulex Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Singulex Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Singulex Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Singulex Raises US$55 Million In Financing Round 10
Singulex Raises US$12 Million In Series G Financing 11
Singulex Raises US$15.3 Million In Venture Financing 12
Singulex Secures USD15.34 Million in Series F Round of Fundingq 13
Singulex Secures An Additional US$2.17 Million In Venture Financing 14
Partnerships 15
Singulex Enters into Licensing agreement with Thermo Fisher Scientific 15
Singulex Enters into Licensing Agreement with Grifols 16
Singulex Enters into Agreement with Qiagen 17
Singulex Forms Joint Venture with Technology Foundation STW 18
Singulex Enters into Development Agreement with CHDI Foundation 19
Singulex Enters Into Co-Development Agreement With Tecan 20
Equity Offering 21
Grifols Invests USD50 Million in Singulex 21
Singulex Withdrawn IPO For Up To US$86 Million 22
Singulex Inc – Key Competitors 23
Singulex Inc – Key Employees 24
Singulex Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 25
Recent Developments 26
Strategy And Business Planning 26
Dec 20, 2016: Singulex Opens European Office and Advances IVD System Evaluation 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Singulex Inc, Medical Equipment, Key Facts 2
Singulex Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Singulex Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Singulex Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Singulex Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Singulex Inc, Deals By Market, 2011 to YTD 2017 8
Singulex Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Singulex Raises US$55 Million In Financing Round 10
Singulex Raises US$12 Million In Series G Financing 11
Singulex Raises US$15.3 Million In Venture Financing 12
Singulex Secures USD15.34 Million in Series F Round of Fundingq 13
Singulex Secures An Additional US$2.17 Million In Venture Financing 14
Singulex Enters into Licensing agreement with Thermo Fisher Scientific 15
Singulex Enters into Licensing Agreement with Grifols 16
Singulex Enters into Agreement with Qiagen 17
Singulex Forms Joint Venture with Technology Foundation STW 18
Singulex Enters into Development Agreement with CHDI Foundation 19
Singulex Enters Into Co-Development Agreement With Tecan 20
Grifols Invests USD50 Million in Singulex 21
Singulex Withdrawn IPO For Up To US$86 Million 22
Singulex Inc, Key Competitors 23
Singulex Inc, Key Employees 24
Singulex Inc, Joint Venture 25

★海外企業調査レポート[Singulex Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ohishi Sangyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Ohishi Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ohishi Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Amedica Corp (AMDA):医療機器:M&Aディール及び事業提携情報
    Summary Amedica Corp (Amedica) is a biomaterial company that develops, produces and markets medical-grade silicon nitride ceramics for spinal implants and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems. It also offers non-silicon …
  • Trimedyne Inc:企業の戦略的SWOT分析
    Trimedyne Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • BioClinica Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioClinica Inc (BioClinica), formerly Bio-Imaging Technologies, Inc., is a clinical trials services provider. The company’s cloud-based offerings comprise medical image management solutions; electronic data capture (EDC) solutions; clinical data management; clinical trial management systems …
  • Spero Therapeutics Inc (SPRO):製薬・医療:M&Aディール及び事業提携情報
    Summary Spero Therapeutics Inc. (Spero) is a clinical-stage biopharmaceutical company. It is engaged in developing, identifying and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections. Its product pipeline includes SPR994 oral gram-negative program, SPR741and SPR206 …
  • Teijin Limited:企業の戦略・SWOT・財務情報
    Teijin Limited - Strategy, SWOT and Corporate Finance Report Summary Teijin Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Horizon Oil Ltd (HZN):企業の財務・戦略的SWOT分析
    Summary Horizon Oil Ltd (Horizon) is an oil and gas exploration and production company that acquires, explores, develops and produces oil and petroleum properties. The company holds interests in Maari and Manaia fields located in the Taranaki Basin approximately 80 kilometre offshore the north islan …
  • Polyplus-Transfection SA-製薬・医療分野:企業M&A・提携分析
    Summary Polyplus-Transfection SA (Polyplus) is a biotechnology company that develops and markets solutions for in vivo and in vitro delivery of nucleic acids in research, bioproduction and therapeutics. The company develops its RNA interference such as STICKY SIRNA and SIRNAPLUS for invivo research. …
  • VVC Exploration Corp (VVC):企業の財務・戦略的SWOT分析
    Summary VVC Exploration Corp (VVC) is a mining and mineral exploration company. It is involved in acquisition, exploration, and development of gold, copper, silver, and other mineral properties. Its projects portfolio includes Gloria, Cumeral, La Tuna, and Timmins projects. VVC also offers open-pit …
  • Karus Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Karus Therapeutics Ltd (Karus) is a drug development company that designs and develops cancer therapies. The company offers small molecule drugs with immunotherapy for the treatment of hematological and solid tumors. Its pipeline products include KA2507 and KA2237 inhibitors. Karus’ KA2507 i …
  • Abcam Plc (ABC)-医療機器分野:企業M&A・提携分析
    Summary Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondar …
  • United Orthopedic Corp (4129)-医療機器分野:企業M&A・提携分析
    Summary United Orthopedic Corp (UOC) is a medical device company that designs, manufactures and distributes orthopedic implants and instrument sets. The company’s product categories include knee replacement systems, hip replacement systems, and oncology products. Its hip replacement systems include …
  • PPG Industries, Inc.:企業のM&A・事業提携・投資動向
    PPG Industries, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PPG Industries, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Companhia Energetica de Minas Gerais – CEMIG:企業の戦略・SWOT・財務情報
    Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report Summary Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Aju Pharm Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Aju Pharm Co Ltd (Aju Pharm) is a pharma and medical device company. The company operates in the business such as pharmaceutical, CMO, medical device, global business and consumer health business. Its pharmaceutical business provides drugs for hypertension, antibiotics, and anti-inflammatory …
  • Fortum Corp (FORTUM):石油・ガス:M&Aディール及び事業提携情報
    Summary Fortum Corp (Fortum) is a clean energy company, which generates, distributes and sells heat and electricity. The company undertakes operation and maintenance of power plants; and offers energy-related services. Fortum's operational assets include hydropower plants, condensing power plants, w …
  • Broadwind Energy, Inc. (BWEN)-エネルギー分野:企業M&A・提携分析
    Summary Broadwind Energy, Inc. (Broadwind) is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. It offers a wide range of products from gears and gearing systems, to wind turbine towers, fabrications and industrial weldments. B …
  • China Pacific Insurance (Group) Co Ltd:企業のM&A・事業提携・投資動向
    China Pacific Insurance (Group) Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Pacific Insurance (Group) Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Tipco Foods Public Company Limited :企業の戦略・SWOT・財務情報
    Tipco Foods Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Tipco Foods Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Riverbed Technology Inc:企業の戦略的SWOT分析
    Riverbed Technology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆